Related Experiment Video
Updated: Feb 12, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Understanding the role of non-coding RNA (ncRNA) in stent restenosis
Shaoyan Liu1, Yanyan Yang2, Shaoyan Jiang3
1Department of Cardiology, The Affiliated Hospital of Qingdao University, 266000, People's Republic of China.
Insights
Coronary heart disease treatments like stents can cause complications. Non-coding RNAs (ncRNAs) show promise in regulating vascular responses and may offer new targets to prevent stent restenosis and thrombosis.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Biomedical Engineering
Background:
- Coronary heart disease (CHD) is a leading cause of mortality.
- Percutaneous coronary intervention with stent implantation is standard treatment for obstructive coronary artery disease.
- Stents, as foreign bodies, can trigger vascular smooth muscle cell proliferation, immune responses, and neointima formation, leading to post-stent restenosis (ISR) and late thrombosis.
Purpose of the Study:
- To review the regulatory roles of non-coding RNAs (ncRNAs) in cardiovascular disease.
- To explore the potential of ncRNAs as therapeutic targets for preventing adverse vascular events after stent implantation.
Main Methods:
- Literature review of studies on ncRNAs and cardiovascular disease.
- Analysis of ncRNA regulatory mechanisms in vascular cells and inflammatory processes.
- Synthesis of current knowledge on ncRNAs in the context of coronary stenting.
Main Results:
- Non-coding RNAs (ncRNAs) are key regulators of endothelial and vascular smooth muscle cell function.
- ncRNAs play significant roles in modulating inflammatory reactions relevant to cardiovascular pathology.
- Specific ncRNAs have been implicated in the processes leading to ISR and thrombosis.
Conclusions:
- ncRNAs represent a novel class of molecules with significant potential in cardiovascular disease regulation.
- Targeting ncRNAs may offer a promising therapeutic strategy to prevent stent-related complications like ISR and thrombosis.
- Further research into ncRNA mechanisms could lead to improved outcomes for patients undergoing coronary stenting.
Abstract:
Coronary heart disease (CHD) is one of the leading disorders with the highest mortality rate. Percutaneous angioplasty and stent implantation are the currently available standard methods for the treatment of obstructive coronary artery disease. However, the stent being an exogenous substance causes several complications by promoting the proliferation of vascular smooth muscle cells, immune responses and neointima formation after implantation, leading to post-stent restenosis (ISR) and late thrombosis. The prevention of these adverse vascular events is important to achieve long-term proper functioning of the heart after stent implantation. Non-coding ribonucleic acids (ncRNAs) are RNA molecules not translated into proteins, theyhave a great potential in regulating endothelial cell and vascular smooth muscle function as well as inflammatory reactions. In this review, we outline the regulatory functions of different classes of ncRNA in cardiovascular disease and propose ncRNAs as new targets for stent restonosis treatment.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Understanding the Self
RNA Splicing
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
RNA Stability

